Literature DB >> 12905014

Congenital disorder of glycosylation type 1a in a macrosomic 16-month-old boy with an atypical phenotype and homozygosity of the N216I mutation.

Luitgard M Neumann1, Arpad von Moers, Jürgen Kunze, Oliver Blankenstein, Thorsten Marquardt.   

Abstract

UNLABELLED: We report on a 16-month-old boy with congenital disorder of glycosylation type 1a (CDG-1a; OMIM 212065) showing an atypical phenotype. Whereas failure to thrive is known to be a prominent feature in this condition, our patient developed postnatal macrosomia with increase of weight, length and occipitofrontal circumference (OFC) above the 95th percentile within his 1st year of life. Thereafter, weight and length were close to the 90th and OFC at the 50th percentiles. In contrast to other CDG-1a patients, the child did not have abnormal fat pads or inverted nipples; but unusual eyebrows were present. CDG-1a was confirmed by isoelectric focusing of serum transferrin and measurement of phosphomannomutase activity in leucocytes and cultured fibroblasts (residual activity <5% of controls). Mutation analysis of the phosphomannomutase 2 gene (PMM2) revealed homozygosity for a 647A>T (N216I) mutation in our patient and heterozygosity in his consanguineous parents.
CONCLUSION: This is the first report of macrosomia and of homozygosity for the 647A>T (N216I) mutation in a patient with congenital disorder of glycosylation type 1a which may allow further phenotype/genotype comparisons.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12905014     DOI: 10.1007/s00431-003-1278-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  11 in total

Review 1.  The carbohydrate-deficient glycoprotein syndrome. A new inherited multisystemic disease with severe nervous system involvement.

Authors:  J Jaeken; H Stibler; B Hagberg
Journal:  Acta Paediatr Scand Suppl       Date:  1991

2.  Clinical and molecular features of congenital disorder of glycosylation in patients with type 1 sialotransferrin pattern and diverse ethnic origins.

Authors:  Gregory M Enns; Robert D Steiner; Neil Buist; Charles Cowan; Kathleen A Leppig; Marjorie F McCracken; Vibeke Westphal; Hudson H Freeze; John F O'brien; Jaak Jaeken; Gert Matthijs; Sarina Behera; Louanne Hudgins
Journal:  J Pediatr       Date:  2002-11       Impact factor: 4.406

Review 3.  Congenital disorders of glycosylation: a review.

Authors:  Stephanie Grunewald; Gert Matthijs; Jaak Jaeken
Journal:  Pediatr Res       Date:  2002-11       Impact factor: 3.756

4.  Scandinavian CDG-Ia patients: genotype/phenotype correlation and geographic origin of founder mutations.

Authors:  A Erlandson; C Bjursell; H Stibler; B Kristiansson; J Wahlström; T Martinsson
Journal:  Hum Genet       Date:  2001-05       Impact factor: 4.132

5.  Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome).

Authors:  G Matthijs; E Schollen; E Pardon; M Veiga-Da-Cunha; J Jaeken; J J Cassiman; E Van Schaftingen
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

6.  Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).

Authors:  G Matthijs; E Schollen; C Bjursell; A Erlandson; H Freeze; F Imtiaz; S Kjaergaard; T Martinsson; M Schwartz; N Seta; S Vuillaumier-Barrot; V Westphal; B Winchester
Journal:  Hum Mutat       Date:  2000-11       Impact factor: 4.878

7.  Severe transient myocardial ischaemia caused by hypertrophic cardiomyopathy in a patient with congenital disorder of glycosylation type Ia.

Authors:  Thorsten Marquardt; Georg Hülskamp; Josef Gehrmann; Volker Debus; Erik Harms; Hans Gerd Kehl
Journal:  Eur J Pediatr       Date:  2002-08-22       Impact factor: 3.183

8.  Prepubertal growth in congenital disorder of glycosylation type Ia (CDG-Ia).

Authors:  S Kjaergaard; J Müller; F Skovby
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

Review 9.  Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies.

Authors:  T Marquardt; J Denecke
Journal:  Eur J Pediatr       Date:  2003-03-15       Impact factor: 3.183

10.  Thyroid function tests and characterization of thyroxine-binding globulin in the carbohydrate-deficient glycoprotein syndrome type I.

Authors:  P E Macchia; H H Harrison; N H Scherberg; T Sunthornthepfvarakul; J Jaeken; S Refetoff
Journal:  J Clin Endocrinol Metab       Date:  1995-12       Impact factor: 5.958

View more
  2 in total

1.  The Prevalence of PMM2-CDG in Estonia Based on Population Carrier Frequencies and Diagnosed Patients.

Authors:  Mari-Anne Vals; Sander Pajusalu; Mart Kals; Reedik Mägi; Katrin Õunap
Journal:  JIMD Rep       Date:  2017-07-07

2.  DFT investigation on the reaction mechanism catalyzed by α-phosphomannomutase1 in protonated/deprotonated states.

Authors:  Hui-Ying Chu; Qing-Chuan Zheng; Xue Li; Yong-Shan Zhao; Ji-Long Zhang; Hong-Xing Zhang
Journal:  J Mol Model       Date:  2010-05-30       Impact factor: 1.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.